Are you looking to develop an early cost-effectiveness model?
Lumanity’s Margarita Kulakova, Daniel Gladwell, and Jake Horgan have produced a guide outlining how these models can support the value demonstration strategy of a medicinal product by providing insights into its position in the treatment landscape, key value drivers, and potential evidence gaps.
Discover how to leverage these models for strategic decision-making and avoid future pitfalls by following our step-by-step approach.
Fill out the form on the right to download the guide.
Download the guide
"*" indicates required fields
